Literature DB >> 22854534

Prediction of 3-hydroxypyridin-4-one (HPO) log K1 values for Fe(III).

Yu-Lin Chen1, Dave J Barlow, Xiao-Le Kong, Yong-Min Ma, Robert C Hider.   

Abstract

As a means to aid in the design of 3-hydroxypyridin-4-ones (HPOs) intended for use as therapeutic Fe(3+) chelating agents, a novel methodology has been developed using quantum mechanical (QM) calculations for predicting the iron binding affinities of the compounds (more specifically, their log K(1) values). The reported/measured HPO log K(1) values were verified through their correlation with the corresponding sum of the compounds' ligating group pK(a) values. Using a training set of eleven HPOs with known log K(1) values, reliable predictions are shown to be obtained with QM calculations using the B3LYP/6-31+G(d)/CPCM model chemistry (with Bondi radii, and water as solvent). With this methodology, the observed log K(1) values for the training set compounds are closely matched by the predicted values, with the correlation between the observed and predicted values giving r(2) = 0.9. Predictions subsequently made by this method for a test set of 42 HPOs of known log K(1) values gave predicted values accurate to within ±0.32 log units. In order to further investigate the predictive power of the method, four novel HPOs were synthesised and their log K(1) values were determined experimentally. Comparison of these predicted log K(1) values against the measured values gave absolute deviations of 0.22 (13.87 vs. 14.09), 0.02 (14.31 vs. 14.29), 0.12 (14.62 vs. 14.50), and 0.13 (15.04 vs. 15.17). The prediction methodology reported here is the first to be provided for predicting the absolute log K(1) values of iron-chelating agents in the absence of pK(a) values.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854534     DOI: 10.1039/c2dt31254a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity.

Authors:  Zhisheng Mi; Bing Gan; Sihang Yu; Jianan Guo; Changjun Zhang; Xiaoying Jiang; Tao Zhou; Jing Su; Renren Bai; Yuanyuan Xie
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands.

Authors:  Vafa Sheikhmoradi; Sedigheh Saberi; Lotfollah Saghaei; Nader Pestehchian; Afshin Fassihi
Journal:  Res Pharm Sci       Date:  2018-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.